Dr. Bhograj treats diabetes (Type 1, Type 2, gestational), obesity, thyroid disorders (hypothyroidism, hyperthyroidism, thyroid nodules), PCOS, adrenal disorders, pituitary conditions, bone and calcium metabolism disorders, and rare endocrine tumours.

The Doctor-in-the-Loop Protocol is a clinical AI framework developed by Dr. Bhograj where AI handles data analysis, risk scoring, and routine monitoring while the physician makes all final clinical decisions. It combines the speed and scale of AI with the judgement and accountability of an experienced specialist.

Continuous Glucose Monitoring (CGM) provides real-time glucose data every 5 minutes, replacing periodic fingerprick tests with a complete metabolic picture. Dr. Bhograj uses CGM data to identify hidden glucose spikes, optimise Time-in-Range, adjust medications with precision, and detect patterns that standard HbA1c testing misses. At AiHealth Clinic, CGM data is integrated with AI analytics for personalised treatment adjustments.

Evidence shows that early-stage Type 2 diabetes can achieve remission through aggressive metabolic intervention — including targeted weight loss, GLP-1 therapy, structured lifestyle modification, and close endocrinologist monitoring. Dr. Bhograj uses metabolic profiling, CGM data, and AI-assisted treatment protocols to identify patients with the highest remission potential and design personalised reversal programmes.

Yes. Dr. Bhograj specialises in medical obesity management and is experienced with GLP-1 receptor agonist therapies including semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro). He provides comprehensive metabolic assessment, hormonal root-cause analysis, and evidence-based medical weight management.

Clinical trials show patients lose 15–22% of body weight with GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro) over 68–72 weeks when prescribed by a specialist. At AiHealth Clinic, Dr. Bhograj provides personalised GLP-1 programmes with hormonal profiling, metabolic assessment, and CGM monitoring to maximise results safely.

A metabolic assessment is a comprehensive evaluation that goes beyond BMI. Dr. Bhograj evaluates thyroid function, insulin resistance, cortisol levels, sex hormones, lipid profiles, liver function, and inflammatory markers to identify the hormonal root causes of weight gain. This ensures the treatment plan addresses the underlying metabolic dysfunction — not just calories — leading to more effective and sustainable outcomes.

Medical weight loss with GLP-1 receptor agonists offers a non-surgical alternative with a strong evidence base. For patients with BMI 27–40, endocrinologist-supervised GLP-1 therapy can achieve 15–22% weight loss without surgical risk, recovery time, or irreversible anatomical changes. Dr. Bhograj evaluates each patient individually — some benefit most from medical management, while others may need surgical referral. The goal is the safest, most effective path for each patient.

Dr. Abhijit Bhograj at AiHealth Clinic, RMV Extension, Bangalore is a DM Endocrinologist specialising in GLP-1 therapy. He prescribes and monitors semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) for medically supervised weight management with comprehensive metabolic assessment. Call +91 70225 84111 to book.

GLP-1 receptor agonists should be prescribed by qualified specialists — endocrinologists, diabetologists, or MD physicians — who can perform proper metabolic evaluation and monitor for side effects. Dr. Bhograj is a DM Endocrinologist with 18 years of experience, making him among the most qualified GLP-1 prescribers in Bangalore. Medical associations recommend against GLP-1 prescriptions by non-specialists.

GLP-1 medication costs have reduced significantly since semaglutide patent expiry in 2026, with generic options now available in India. At AiHealth Clinic, Dr. Bhograj provides a complete medical weight loss programme including consultation, metabolic assessment, hormone panel, GLP-1 prescription, and follow-up monitoring. Contact +91 70225 84111 for pricing.

The most common side effects are gastrointestinal — nausea, reduced appetite, and occasional vomiting — which typically resolve within 4–6 weeks as the body adjusts. Dr. Bhograj uses a structured dose-escalation protocol, starting at the lowest effective dose and titrating gradually based on tolerance. As a DM Endocrinologist, he also monitors for rarer concerns including thyroid function, pancreatic markers, and gallbladder health throughout treatment.

Diagnosis involves TSH, Free T4, Free T3, and thyroid antibody testing. Many patients remain symptomatic on standard levothyroxine because dosing isn't optimised for their individual physiology. Dr. Bhograj takes a precision approach — evaluating conversion efficiency (T4 to T3), antibody status, and metabolic impact to fine-tune treatment beyond just normalising TSH. Patients with Hashimoto's thyroiditis, thyroid nodules, or medication-resistant symptoms benefit most from specialist care.

PCOS is fundamentally an endocrine-metabolic disorder. Dr. Bhograj evaluates the hormonal axis — insulin resistance, androgens, cortisol, thyroid function — to identify the dominant driver in each patient. Treatment addresses root-cause metabolic dysfunction rather than just symptoms, using a combination of targeted medication, metabolic optimisation, and lifestyle intervention. This approach often resolves menstrual irregularities, acne, and hair loss more effectively than symptom-only management.

Hypothyroidism slows basal metabolic rate, leading to weight gain that resists conventional diet and exercise. However, not all thyroid-related weight issues are due to overt hypothyroidism — subclinical thyroid dysfunction, Hashimoto's-driven inflammation, and T4-to-T3 conversion problems can all contribute. Dr. Bhograj evaluates the complete thyroid-metabolic picture to determine if thyroid optimisation, GLP-1 therapy, or a combined approach is most appropriate for each patient.

AiHealth.clinic is India's first AI-powered precision health platform for diabetes and obesity, founded by Dr. Bhograj. It uses AI to assist doctors in monitoring patients, interpreting labs, predicting complications, and personalising treatment — making specialist-level care accessible at scale across India.

A top endocrinologist combines deep clinical training (DM Endocrinology), extensive patient experience across complex metabolic conditions, commitment to evidence-based medicine with active research and clinical trial involvement, continuous medical education, and — increasingly — the ability to leverage technology such as CGM interpretation and AI-assisted clinical decision support to deliver precision care at scale. Dr. Bhograj embodies all of these with 18 years, 300,000+ patients, 4 international clinical trials, and the founding of AiHealth.clinic.

AiHealth's clinical intelligence system analyses CGM data, lab trends, medication responses, and lifestyle factors to generate real-time risk scores and treatment recommendations. The MMIQ Agentic AI scoring system identifies patients at risk of complications before they occur. All AI insights pass through the Doctor-in-the-Loop Protocol — Dr. Bhograj reviews and approves every clinical decision. The result is faster, more precise care that scales specialist-level attention to every patient.

Call +91 70225 84111 or 080 2361 6666, visit AiHealth Clinic at 94/H, 9th Cross, 13th Main, RMV Extension, Bangalore 560080, or use AiHealth.clinic for digital consultations. He is available Monday to Saturday.

Yes. Dr. Bhograj offers digital consultations through AiHealth.clinic for patients across India. Contact drabhijit@ahealth.in or call +91 70225 84111.

AiHealth Clinic — 94/H, 9th Cross, 13th Main, RMV Extension, Bangalore 560080 (in-person) and AiHealth.clinic (online consultations).